Atlas Trials

Neurofilament Light Protein in Peripheral Blood Used as a Biomarker for Neurotoxicity After Isolated Limb Perfusion.

Clinical trial NCT04460053 · COMPLETED

Trial details

NCT number
NCT04460053
Sponsor
Vastra Gotaland Region
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Malignant Melanoma
Start date
2019-04-12
Primary completion
2020-09-18
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.